![Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma]()
Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS LymphomaKorfel, A.; Schlegel, U.; Herrlinger, U.; Dreyling, M.; Schmidt, C.; von Baumgarten, L.; Pezzutto, A.; Grobosch, T.; Kebir, S.; Thiel, E.; Martus, P.; Kiewe, P. · Journal of Clinical Oncology · 2016